513 related articles for article (PubMed ID: 25385035)
1. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.
Favier J; Amar L; Gimenez-Roqueplo AP
Nat Rev Endocrinol; 2015 Feb; 11(2):101-11. PubMed ID: 25385035
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma and paraganglioma: molecular testing and personalized medicine.
Burnichon N; Buffet A; Gimenez-Roqueplo AP
Curr Opin Oncol; 2016 Jan; 28(1):5-10. PubMed ID: 26599293
[TBL] [Abstract][Full Text] [Related]
3. Pathology and genetics of phaeochromocytoma and paraganglioma.
Turchini J; Cheung VKY; Tischler AS; De Krijger RR; Gill AJ
Histopathology; 2018 Jan; 72(1):97-105. PubMed ID: 29239044
[TBL] [Abstract][Full Text] [Related]
4. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
5. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
6. SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma.
Bayley JP; Kunst HP; Cascon A; Sampietro ML; Gaal J; Korpershoek E; Hinojar-Gutierrez A; Timmers HJ; Hoefsloot LH; Hermsen MA; Suárez C; Hussain AK; Vriends AH; Hes FJ; Jansen JC; Tops CM; Corssmit EP; de Knijff P; Lenders JW; Cremers CW; Devilee P; Dinjens WN; de Krijger RR; Robledo M
Lancet Oncol; 2010 Apr; 11(4):366-72. PubMed ID: 20071235
[TBL] [Abstract][Full Text] [Related]
7. SDHD immunohistochemistry: a new tool to validate SDHx mutations in pheochromocytoma/paraganglioma.
Menara M; Oudijk L; Badoual C; Bertherat J; Lepoutre-Lussey C; Amar L; Iturrioz X; Sibony M; Zinzindohoué F; de Krijger R; Gimenez-Roqueplo AP; Favier J
J Clin Endocrinol Metab; 2015 Feb; 100(2):E287-91. PubMed ID: 25405498
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-210 is associated with SDH-related pheochromocytomas, paragangliomas, and gastrointestinal stromal tumours.
Tsang VH; Dwight T; Benn DE; Meyer-Rochow GY; Gill AJ; Sywak M; Sidhu S; Veivers D; Sue CM; Robinson BG; Clifton-Bligh RJ; Parker NR
Endocr Relat Cancer; 2014 Jun; 21(3):415-26. PubMed ID: 24623741
[TBL] [Abstract][Full Text] [Related]
9. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide.
Chatzikyriakou P; Brempou D; Quinn M; Fishbein L; Noberini R; Anastopoulos IN; Tufton N; Lim ES; Obholzer R; Hubbard JG; Moonim M; Bonaldi T; Nathanson KL; Izatt L; Oakey RJ
Clin Epigenetics; 2023 Dec; 15(1):196. PubMed ID: 38124114
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis of patients with pediatric pheochromocytoma.
Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
[TBL] [Abstract][Full Text] [Related]
12. Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.
Daniel E; Jones R; Bull M; Newell-Price J
Eur J Endocrinol; 2016 Dec; 175(6):561-570. PubMed ID: 27634942
[TBL] [Abstract][Full Text] [Related]
13. Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
Burnichon N; Vescovo L; Amar L; Libé R; de Reynies A; Venisse A; Jouanno E; Laurendeau I; Parfait B; Bertherat J; Plouin PF; Jeunemaitre X; Favier J; Gimenez-Roqueplo AP
Hum Mol Genet; 2011 Oct; 20(20):3974-85. PubMed ID: 21784903
[TBL] [Abstract][Full Text] [Related]
14. Germline mutations and genotype-phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma.
Pandit R; Khadilkar K; Sarathi V; Kasaliwal R; Goroshi M; Khare S; Nair S; Raghavan V; Dalvi A; Hira P; Fernandes G; Sathe P; Rojekar A; Malhotra G; Bakshi G; Prakash G; Bhansali A; Walia R; Kamalanathan S; Sahoo J; Desai A; Bhagwat N; Mappa P; Rajput R; Chandrashekhar SR; Shivane V; Menon P; Lila A; Bandgar T; Shah N
Eur J Endocrinol; 2016 Oct; 175(4):311-23. PubMed ID: 27539324
[TBL] [Abstract][Full Text] [Related]
15. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
16. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours.
Loughrey PB; Roncaroli F; Healy E; Weir P; Basetti M; Casey RT; Hunter SJ; Korbonits M
Endocr Relat Cancer; 2022 Oct; 29(10):R157-R172. PubMed ID: 35938916
[TBL] [Abstract][Full Text] [Related]
17. An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes.
Gimenez-Roqueplo AP; Dahia PL; Robledo M
Horm Metab Res; 2012 May; 44(5):328-33. PubMed ID: 22328163
[TBL] [Abstract][Full Text] [Related]
18. Phaeochromocytoma, new genes and screening strategies.
Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
[TBL] [Abstract][Full Text] [Related]
19. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations and genotype-phenotype correlations in patients with apparently sporadic pheochromocytoma/paraganglioma in Korea.
Kim JH; Seong MW; Lee KE; Choi HJ; Ku EJ; Bae JH; Park SS; Choi SH; Kim SW; Shin C; Kim SY
Clin Genet; 2014 Nov; 86(5):482-6. PubMed ID: 24134185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]